The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGresham Regulatory News (GHT)

Share Price Information for Gresham (GHT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 163.00
Bid: 162.00
Ask: 164.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.235%)
Open: 163.00
High: 163.00
Low: 159.00
Prev. Close: 163.00
GHT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Significant New Clareti Contract Win

3 Jul 2017 07:00

RNS Number : 8398J
Gresham Technologies PLC
03 July 2017
 

3 July 2017

Gresham Technologies plc

Significant new Clareti win with Canadian banking group

Gresham Technologies plc (LSE: "GHT", "Gresham" or the "Group"), the leading software and services company that specialises in providing real-time transaction control and enterprise data integrity solutions, is pleased to announce a significant contract win in the strategically important North American market.

One of North America's largest financial services groups has selected Clareti Transaction Control (CTC) for an enterprise scale deployment. The initial deployment will be to provide ongoing data integrity assurance for complex regulatory reporting requirements. In addition, the solution will replace existing manually intensive reconciliation and control processes in the customer's securities division. The customer will also deploy Clareti Analytics to provide deeper management insight into its data control operations. 

The minimum contracted value is £1.4m over the initial five year term, with additional licence growth and services revenues expected as the technology is deployed further in the customer's group.

Ian Manocha, CEO, commented:

"This is the third new CTC customer win in North America this year, and follows on from our first US Tier 1 bank win in late 2016.

 

The pace of change in the US & Canadian financial markets is accelerating and participants are finding themselves constrained by their data processing infrastructure. This leaves them with a myriad of potential control gaps, and an inability to keep up with complex regulatory reporting demands. We continue to invest in the North American market to capitalise on this opportunity."

 

Enquiries

Gresham Technologies plc

+44 (0) 207 653 0200

Ian Manocha

Rob Grubb

N+1 Singer (Broker)

+44 (0) 207 496 3000

Shaun Dobson

Lauren Kettle

 

Note to editors

Gresham's award-winning Clareti software platform has been designed to provide financial institutions with complete certainty in their data processing. Clareti is a highly flexible and fully scalable platform for assuring enterprise data integrity and is designed to address today's most challenging financial control, internal risk management, data governance and regulatory compliance problems. Gresham's portfolio of applications based on the Clareti platform, including Clareti Transaction Control (CTC), Clareti Accounts Receivable Management (Clareti ARM) and Clareti Loan Control (CLC), provide innovative industry and domain specific solutions for real-time data management based on business-driven controls.

Gresham Technologies plc is a leading software and services company that specialises in providing real-time transaction control and enterprise data integrity solutions. Listed on the main market of the London Stock Exchange (GHT.L) and headquartered in the City of London, customers include some of the world's largest financial institutions, all of whom are served locally from offices located in Europe, North America and Asia Pacific.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUGUMWMUPMUUP
Date   Source Headline
1st Jun 20153:05 pmRNSDirectors' Dealings
1st Jun 201512:29 pmRNSGrant of Options
1st Jun 20157:00 amRNSBoard Changes Effective
29th May 20151:30 pmRNSDirector/PDMR Shareholding
18th May 20152:36 pmRNSDirector/PDMR Shareholding
7th May 201512:18 pmRNSResult of AGM
7th May 20157:00 amRNSAGM Statement
27th Apr 201510:07 amRNSDirector/PDMR Shareholding
20th Apr 201511:15 amRNSDirector/PDMR Shareholding
9th Apr 201512:36 pmRNSDirector/PDMR Shareholding
7th Apr 20157:00 amRNSCTC Contract Win
31st Mar 201510:42 amRNSNotice of AGM
24th Mar 20157:01 amRNSProposed Resolution to Purchase Own Shares
24th Mar 20157:00 amRNSAnnual Financial Report
20th Mar 20153:27 pmRNSReduction of Capital Effective
6th Mar 20154:38 pmRNSHolding(s) in Company
5th Mar 20157:00 amRNSDirectorate Change
26th Feb 201512:18 pmRNSHolding(s) in Company
24th Feb 201512:45 pmRNSResult of EGM
11th Feb 20152:04 pmRNSDirector Declaration
10th Feb 20157:00 amRNSCTC Contract Win
27th Jan 20157:02 amRNSDirectorate Change
27th Jan 20157:01 amRNSCancellation of Share Premium Acct. & Notice of GM
27th Jan 20157:01 amRNSTrading Update
29th Dec 20147:00 amRNSCTC Contract Win
10th Dec 20147:00 amRNSCTC Contract Win
21st Nov 20147:00 amRNSCTC Contract Extension
13th Nov 20147:00 amRNSCTC Contract Wins
4th Nov 20147:00 amRNSCTC Contract Win
3rd Nov 20145:04 pmRNSHolding(s) in Company
13th Oct 20145:14 pmRNSHolding(s) in Company
10th Oct 201412:52 pmRNSDirector/PDMR Shareholding
10th Oct 20147:00 amRNSDirector/PDMR Shareholding
9th Oct 20147:00 amRNSInterim Management Statement
2nd Sep 20147:00 amRNSDirector/PDMR Shareholding
26th Aug 20144:00 pmRNSDirector/PDMR Shareholding
14th Aug 20147:00 amRNSDirector/PDMR Shareholding
13th Aug 201411:23 amRNSDirector/PDMR Shareholding
11th Aug 20147:00 amRNSHalf Yearly Report
1st Jul 20142:34 pmRNSDirector/PDMR Shareholding
23rd Jun 20143:13 pmRNSDirector/PDMR Shareholding
23rd Jun 20147:00 amRNSDirector/PDMR Shareholding
19th Jun 20142:32 pmRNSDirector/PDMR Shareholding
19th Jun 20147:00 amRNSDirectorate Change
16th Jun 20142:44 pmRNSDirector/PDMR Shareholding
13th Jun 20147:00 amRNSDirector/PDMR Shareholding
21st May 20144:17 pmRNSDirector's Dealing
20th May 20147:00 amRNSDirector/PDMR Shareholding
19th May 20147:00 amRNSInterim Management Statement
15th May 20147:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.